Hot Features
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment o... Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.13 | -2.88888888889 | 4.5 | 4.74 | 4 | 158467 | 4.34650492 | CS |
| 4 | -0.61 | -12.2489959839 | 4.98 | 5.26 | 4 | 144621 | 4.52075737 | CS |
| 12 | -0.88 | -16.7619047619 | 5.25 | 7.58 | 4 | 163256 | 5.44006937 | CS |
| 26 | 0.42 | 10.6329113924 | 3.95 | 8.8 | 3.75 | 184557 | 6.09349569 | CS |
| 52 | 2.47 | 130 | 1.9 | 12.46 | 1.566 | 837838 | 6.09908358 | CS |
| 156 | -1.65 | -27.4086378738 | 6.02 | 13.49 | 1.15 | 379648 | 6.78684817 | CS |
| 260 | 1.85 | 73.4126984127 | 2.52 | 15.27 | 0.327884 | 628290 | 7.05012573 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.